A Feasibility Study of the Therapeutic Response and Durability of Short-term Androgen-targeted Therapy in Early Prostate Cancer Managed with Surveillance: The Therapeutics in Active Prostate Surveillance (TAPS01) Study

Authors:

Abstract
No abstract available
Funding Information
  • National Institute for Health Research
  • Cancer Research UK
  • UCLH Biomedical Research Centre (BRC-1215-20014)
  • Janssen Global Services LLC
  • Janssen Pharmaceutica

This publication has 30 references indexed in Scilit: